Kane Biotech Inc. (CVE:KNE – Get Free Report)’s share price was down 12.5% during mid-day trading on Monday . The stock traded as low as C$0.04 and last traded at C$0.04. Approximately 138,000 shares changed hands during mid-day trading, a decline of 23% from the average daily volume of 180,043 shares. The stock had previously closed at C$0.04.
Kane Biotech Price Performance
The company has a market cap of C$5.86 million, a price-to-earnings ratio of -0.44 and a beta of 0.43. The company has a current ratio of 0.90, a quick ratio of 0.39 and a debt-to-equity ratio of -289.57. The business has a 50-day moving average price of C$0.04 and a 200 day moving average price of C$0.04.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand.
See Also
- Five stocks we like better than Kane Biotech
- 3 Signs You May Want to Switch Financial Advisors
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- 1,500 Banks Just Handed the Fed Your Bank Account
- A Rockefeller Moment Is Unfolding in Rare Earths
- America’s 1776 happening again
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
